UNSPSC 51292921: Imipramine hydrochloride

This classification denotes a tricyclic antidepressant with the molecular formula C19H24N2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BKE5Q1J60U, chemically known as 5,6-dihydro-n-(3-(dimethylamino)propyl)-11h-dibenz(b,e)azepine but more generally known as imipramine hydrochloride, which bears US NIH Compound Identifier 3696. European Medicines Agency schedules Imipramine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02644MIG.

Most nations, for tariff and trade purposes, schedule imipramine hydrochloride under HS 29339990. As of Q4 2014, IMIPRAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Imipramine hydrochloride bears US NLM identifiers UMLS ID C0589978 and NCI Concept Code C29116. SMILES: CN(C)CCCN1C2CCCCC2CCC3C1CCCC3.CL.

UNSPSC 51292921 Imipramine hydrochloride is a Commodity code nominally identifying a tricyclic antidepressant pharmaceutical. However, the recent state and local procurement activity indexed under this code does not align with the code's stated scope. Seminole County, Florida posted IFB 60459723LAS seeking to procure naloxone (an opioid antagonist used in overdose response) and safe drug deactivation systems—neither of which are imipramine hydrochloride. The mismatch suggests either a cataloging error in the state or local procurement system or a broader coding practice that does not track pharmaceutical commodities by active ingredient at the transaction level. The code shows minimal recent activity, and what activity does appear is unrelated to the pharmaceutical specified in the UNSPSC taxonomy.

Seminole County's naloxone and drug deactivation systems RFQ, posted June 30, 2026 with a response deadline of July 26, 2023, is the only recent solicitation visible under this code. The procurement called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract included a two-year initial term with a one-year renewal option, e-Verify and drug-free workplace certification requirements, and FEMA funding contingencies. No explicit small business, minority-owned business, or other set-aside designations were specified. Without additional activity under this code, no reliable characterization of issuing-body mix, geographic concentration, or procurement momentum is possible.